Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2019 | The heterogeneity of Alzheimer’s disease

Philip Scheltens • 19 Mar 2019
ARUK 2019
Alzheimer’s Disease Dementia

Philip Scheltens, MD, PhD, of VU University Medical Center, Amsterdam, Netherlands, speaks at the Alzheimer’s Research UK (ARUK) Conference 2019, held in Harrogate, UK. He discusses the heterogeneity of Alzheimer’s disease and how this may impact drug trials.

More from Philip Scheltens

1:03
Alzheimer's early diagnosis: challenges and benefits
Philip Scheltens • 19 Mar 2019
1:45
A biological definition of Alzheimer's disease
Philip Scheltens • 19 Mar 2019
1:06
Cerebrospinal fluid (CSF) and imaging biomarkers for the differential diagnosis of dementia
Philip Scheltens • 24 Jun 2017
3:28
Outcome measures in dementia studies
Philip Scheltens • 25 Jun 2017

Related Videos

2:33
Anti-amyloid therapy for Alzheimer's disease: beyond the 18-month mark
Dorota Religa • 22 Mar 2024
0:50
Will long-term anti-amyloid treatment show greater clinical benefit?
Dorota Religa • 22 Mar 2024
1:24
Digital frailty screening in dementia
Dorota Religa • 22 Mar 2024
4:19
Current projects from Alzheimer’s Disease International
Paola Barbarino • 23 Mar 2024
The content of VJDementia is intended for healthcare professionals